Entrada Market Capitalization from 2010 to 2025
Entrada Therapeutics' Market Cap is decreasing over the years with slightly volatile fluctuation. Overall, Market Cap is expected to go to about 659.7 M this year.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Check Entrada Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entrada Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 20.4 M, Interest Income of 20.4 M or Depreciation And Amortization of 3.4 M, as well as many indicators such as Price To Sales Ratio of 3.81, Dividend Yield of 0.0 or PTB Ratio of 1.58. Entrada financial statements analysis is a perfect complement when working with Entrada Therapeutics Valuation or Volatility modules.
Entrada | Market Capitalization |
Latest Entrada Therapeutics' Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Entrada Therapeutics over the last few years. It is Entrada Therapeutics' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Entrada Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 382.53 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Entrada Market Capitalization Regression Statistics
| Arithmetic Mean | 687,095,547 | |
| Geometric Mean | 677,709,687 | |
| Coefficient Of Variation | 15.60 | |
| Mean Deviation | 84,300,366 | |
| Median | 748,404,904 | |
| Standard Deviation | 107,181,780 | |
| Sample Variance | 11487.9T | |
| Range | 325.3M | |
| R-Value | (0.64) | |
| Mean Square Error | 7216.8T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | (14,479,585) | |
| Total Sum of Squares | 172319T |
Entrada Market Capitalization History
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entrada Therapeutics. If investors know Entrada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entrada Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Entrada Therapeutics is measured differently than its book value, which is the value of Entrada that is recorded on the company's balance sheet. Investors also form their own opinion of Entrada Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Entrada Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entrada Therapeutics' market value can be influenced by many factors that don't directly affect Entrada Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entrada Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Entrada Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entrada Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.